Invesque Inc.
MHIVF
$0.12
$0.000.00%
| Weiss Ratings | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.35 | |||
| Price History | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.00% | |||
| 30-Day Total Return | 50.00% | |||
| 60-Day Total Return | 33.33% | |||
| 90-Day Total Return | 33.33% | |||
| Year to Date Total Return | 71.43% | |||
| 1-Year Total Return | -59.32% | |||
| 2-Year Total Return | -86.05% | |||
| 3-Year Total Return | -92.00% | |||
| 5-Year Total Return | -97.85% | |||
| 52-Week High % Change | -60.00% | |||
| 52-Week Low % Change | 300.00% | |||
| Price | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.30 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Oct 10, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 107.95M | |||
| Enterprise Value | 617.83M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.20 | |||
| Earnings Per Share Growth | -26.08% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.04 | |||
| Price/Book (Q) | 0.23 | |||
| Enterprise Value/Revenue (TTM) | 3.44 | |||
| Price | $0.12 | |||
| Enterprise Value/EBITDA (TTM) | 12.26 | |||
| Enterprise Value/EBIT | 17.07 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 56.68M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.06 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.06 | |||
| Company Info | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 333 Bay Street Toronto, ON M5H 2S7 | |||
| Website | invesque.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 20.13% | |||
| Profit Margin | -37.78% | |||
| Management Effectiveness | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.82% | |||
| Return on Equity | -- | |||
| Income Statement | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 170.50M | |||
| Total Revenue (TTM) | 179.68M | |||
| Revenue Per Share | $3.17 | |||
| Gross Profit (TTM) | 58.07M | |||
| EBITDA (TTM) | 50.37M | |||
| EBIT (TTM) | 36.19M | |||
| Net Income (TTM) | -67.89M | |||
| Net Income Avl. to Common (TTM) | -67.89M | |||
| Total Revenue Growth (Q YOY) | -10.03% | |||
| Earnings Growth (Q YOY) | -1,071.24% | |||
| EPS Diluted (TTM) | -1.20 | |||
| EPS Diluted Growth (Q YOY) | -1,961.11% | |||
| Balance Sheet | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 15.32M | |||
| Cash Per Share (Q) | $0.27 | |||
| Total Current Assets (Q) | 421.92M | |||
| Total Preferred Equity (Q) | 85.39 | |||
| Total Equity (Q) | 115.43M | |||
| Current Ratio (Q) | 0.946 | |||
| Book Value Per Share (Q) | $0.52 | |||
| Total Assets (Q) | 711.10M | |||
| Total Current Liabilities (Q) | 446.21M | |||
| Total Debt (Q) | 472.43M | |||
| Total Liabilities (Q) | 595.67M | |||
| Total Common Equity (Q) | 29.48M | |||
| Cash Flow | MHIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 118.16M | |||
| Cash from Financing (TTM) | -127.76M | |||
| Net Change in Cash (TTM) | -5.91M | |||
| Levered Free Cash Flow (TTM) | -250.89M | |||
| Cash from Operations (TTM) | 3.69M | |||
